Brisbane, CA Breaking News Headlines Today

News about Brisbane

Stay current with all the latest and breaking news about Brisbane, compare headlines and perspectives between news sources on stories happening today. In total, 8 stories have been published about Brisbane which Ground News has aggregated in the past 3 months.

Local News Publishers

Untracked bias

Suggest a source

Looking for a source we don't already have? Suggest one here.

Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care – Ortho Spine News

–Public-private partnership aims to improve osteoarthritis research, diagnosis and treatment––PROBE will leverage data from over 70 million individuals across multiple OA cohorts and real-world registries– BRISBANE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Pacira Biosciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced it has joined the PROBEBrisbane · Brisbane Read Article

CareDx Provides Notice of Proposed Derivative Settlement

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) today provided notice of proposed settlement of derivative actions and settlement hearing. UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA JEFFREY EDELMAN, JAYSEN Case No. 3:25-cv-02036-TLT STEVENSON, and CHRISTIAN JACOBSEN, (Shareholder Derivative Action) Derivatively on Behalf of CareDx, Inc., SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF [...] The post Car…Brisbane · Brisbane Read Article

Vera Therapeutics, Inc. (VERA) Stock Analysis: Potential 42% Upside Sparks Investor Interest

Investors with a keen eye on the biotechnology sector may find Vera Therapeutics, Inc. (NASDAQ: VERA) an intriguing prospect. With a market capitalization of $3.49 billion, this clinical-stage biotechnology company is gaining attention for its focus on transformative treatments for serious immunological diseases. Headquartered in Brisbane, California, Vera Therapeutics specializes in developing innovative therapies, including its lead product ca…Brisbane · Brisbane Read Article

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety ...

Coverage: 2 sources

- New data published in Pain Physician shows significant improvement infunctional outcomes with iovera° -Brisbane · Brisbane See the Story

Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors - Vera Therapeutics (NASDAQ:VERA)

100% Center coverage: 1 sources

BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of James R. Meyers, an accomplished biopharmaceutical executive with over three decades of commercial leadership experience to Vera Therapeutics' Board of Directors…Brisbane · Brisbane Read Article

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules - Tempest Therapeutics (NASDAQ:TPST)

100% Center coverage: 1 sources

BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced the closing of its previously announced registered direct offering priced at the market under Nasdaq rules for the purchase and sale of 1,172,414 shares of its common stock (or common stock equivalents), at…Brisbane · Brisbane Read Article

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Annexon (NASDAQ:ANNX)

Coverage: 2 sources

BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. ("Annexon") (NASDAQ:ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced the pricing of its previously announced underwritten public offering of 25,096,153 shares of its common stock at a price to the public of $2.60 per share and, in li…Stock Markets · Brisbane See the Story

Orchard Partners Submits Updated Proposal for 892,000 SQFT Guadalupe Quarry Project in Brisbane

Project to focus on advanced manufacturing. Affirms commitment to completing full environmental impact review. BRISBANE, CALIF. (Nov. 5, 2025) — Orchard Partners today announced it has submitted to the City of Brisbane an updated Project Description and Design Permit Application for the Quarry Innovation Center project proposed at the Guadalupe Quarry near Brisbane, Calif. Informed […] The post Orchard Partners Submits Updated Proposal for 892,0…Brisbane · Brisbane Read Article

Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee – Ortho Spine News

— Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of PCRX-201 — BRISBANE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced updated three-year results and a new subset analyses demonstrating sustained Brisbane · Brisbane Read Article

ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease

100% Right coverage: 1 sources

BRISBANE, Calif. , Oct. 13, 2025 /PRNewswire/ -- ReviR Therapeutics, a biotech company focused on developing novel treatments for neurogenetic diseases, announced today that the...Brisbane · Brisbane Read Article

News about Brisbane

News about Brisbane

Local News Publishers Too Big Arrow Icon

Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care – Ortho Spine News

CareDx Provides Notice of Proposed Derivative Settlement

Vera Therapeutics, Inc. (VERA) Stock Analysis: Potential 42% Upside Sparks Investor Interest

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety ...

Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors - Vera Therapeutics (NASDAQ:VERA)

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules - Tempest Therapeutics (NASDAQ:TPST)

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Annexon (NASDAQ:ANNX)

Orchard Partners Submits Updated Proposal for 892,000 SQFT Guadalupe Quarry Project in Brisbane

Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee – Ortho Spine News

ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease

Local News Publishers Too Big Arrow Icon

Breaking News Topics Related to Brisbane

Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care – Ortho Spine News

CareDx Provides Notice of Proposed Derivative Settlement

Vera Therapeutics, Inc. (VERA) Stock Analysis: Potential 42% Upside Sparks Investor Interest

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety ...

Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors - Vera Therapeutics (NASDAQ:VERA)

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules - Tempest Therapeutics (NASDAQ:TPST)

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Annexon (NASDAQ:ANNX)

Orchard Partners Submits Updated Proposal for 892,000 SQFT Guadalupe Quarry Project in Brisbane

Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee – Ortho Spine News

ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease

Local News Publishers

Local News Publishers